Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 10 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4H344
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 1 |
GO:0004725 | protein tyrosine phosphatase activity | 4 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016791 | phosphatase activity | 5 | 1 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 146 | 150 | PF00656 | 0.451 |
CLV_NRD_NRD_1 | 170 | 172 | PF00675 | 0.450 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.508 |
CLV_NRD_NRD_1 | 200 | 202 | PF00675 | 0.446 |
CLV_NRD_NRD_1 | 224 | 226 | PF00675 | 0.437 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.576 |
CLV_PCSK_FUR_1 | 222 | 226 | PF00082 | 0.300 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.481 |
CLV_PCSK_KEX2_1 | 224 | 226 | PF00082 | 0.437 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.560 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.561 |
CLV_PCSK_SKI1_1 | 227 | 231 | PF00082 | 0.316 |
CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.228 |
DEG_APCC_DBOX_1 | 226 | 234 | PF00400 | 0.472 |
DOC_CYCLIN_yCln2_LP_2 | 133 | 139 | PF00134 | 0.490 |
DOC_MAPK_gen_1 | 74 | 83 | PF00069 | 0.468 |
DOC_MAPK_MEF2A_6 | 76 | 85 | PF00069 | 0.452 |
DOC_PP2B_LxvP_1 | 133 | 136 | PF13499 | 0.417 |
DOC_PP4_FxxP_1 | 128 | 131 | PF00568 | 0.604 |
DOC_USP7_MATH_1 | 107 | 111 | PF00917 | 0.679 |
DOC_WW_Pin1_4 | 155 | 160 | PF00397 | 0.435 |
LIG_14-3-3_CanoR_1 | 15 | 24 | PF00244 | 0.250 |
LIG_14-3-3_CanoR_1 | 151 | 157 | PF00244 | 0.553 |
LIG_Actin_WH2_2 | 180 | 195 | PF00022 | 0.543 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.367 |
LIG_BRCT_BRCA1_1 | 117 | 121 | PF00533 | 0.473 |
LIG_CSL_BTD_1 | 156 | 159 | PF09270 | 0.430 |
LIG_eIF4E_1 | 178 | 184 | PF01652 | 0.422 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.591 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.434 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.369 |
LIG_FHA_2 | 213 | 219 | PF00498 | 0.557 |
LIG_FHA_2 | 246 | 252 | PF00498 | 0.577 |
LIG_FHA_2 | 51 | 57 | PF00498 | 0.452 |
LIG_GBD_Chelix_1 | 233 | 241 | PF00786 | 0.526 |
LIG_HCF-1_HBM_1 | 175 | 178 | PF13415 | 0.462 |
LIG_LIR_Apic_2 | 125 | 131 | PF02991 | 0.561 |
LIG_LIR_Gen_1 | 181 | 192 | PF02991 | 0.442 |
LIG_LIR_Gen_1 | 80 | 89 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 181 | 187 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 78 | 82 | PF02991 | 0.381 |
LIG_PDZ_Class_1 | 261 | 266 | PF00595 | 0.525 |
LIG_Pex14_2 | 24 | 28 | PF04695 | 0.449 |
LIG_SH2_NCK_1 | 258 | 262 | PF00017 | 0.561 |
LIG_SH2_PTP2 | 82 | 85 | PF00017 | 0.387 |
LIG_SH2_STAP1 | 258 | 262 | PF00017 | 0.589 |
LIG_SH2_STAP1 | 79 | 83 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.545 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.387 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.475 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.443 |
LIG_SH3_3 | 82 | 88 | PF00018 | 0.524 |
LIG_SUMO_SIM_par_1 | 47 | 53 | PF11976 | 0.437 |
MOD_CDK_SPK_2 | 155 | 160 | PF00069 | 0.435 |
MOD_CK1_1 | 120 | 126 | PF00069 | 0.616 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.337 |
MOD_CK2_1 | 212 | 218 | PF00069 | 0.510 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.404 |
MOD_CMANNOS | 154 | 157 | PF00535 | 0.435 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.686 |
MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.328 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.707 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.376 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.490 |
MOD_N-GLC_1 | 59 | 64 | PF02516 | 0.223 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.621 |
MOD_NEK2_1 | 229 | 234 | PF00069 | 0.532 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.363 |
MOD_PIKK_1 | 101 | 107 | PF00454 | 0.592 |
MOD_PIKK_1 | 15 | 21 | PF00454 | 0.328 |
MOD_PIKK_1 | 59 | 65 | PF00454 | 0.302 |
MOD_PKA_1 | 99 | 105 | PF00069 | 0.575 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.535 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.614 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.381 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.459 |
MOD_PKA_2 | 99 | 105 | PF00069 | 0.535 |
MOD_Plk_1 | 251 | 257 | PF00069 | 0.493 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.473 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.358 |
MOD_Plk_4 | 245 | 251 | PF00069 | 0.532 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.256 |
MOD_ProDKin_1 | 155 | 161 | PF00069 | 0.434 |
MOD_SUMO_rev_2 | 214 | 221 | PF00179 | 0.572 |
TRG_DiLeu_BaLyEn_6 | 128 | 133 | PF01217 | 0.493 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.387 |
TRG_ER_diArg_1 | 200 | 202 | PF00400 | 0.361 |
TRG_ER_diArg_1 | 223 | 225 | PF00400 | 0.354 |
TRG_ER_diArg_1 | 99 | 101 | PF00400 | 0.603 |
TRG_Pf-PMV_PEXEL_1 | 171 | 175 | PF00026 | 0.555 |
TRG_Pf-PMV_PEXEL_1 | 239 | 244 | PF00026 | 0.491 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILJ3 | Leptomonas seymouri | 61% | 93% |
A0A0S4ING3 | Bodo saltans | 45% | 100% |
A0A1X0P2S0 | Trypanosomatidae | 45% | 80% |
A0A422NY87 | Trypanosoma rangeli | 46% | 94% |
A0A451EJ77 | Leishmania donovani | 84% | 88% |
A4HRE1 | Leishmania infantum | 85% | 88% |
C9ZXF7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AC09 | Leishmania major | 84% | 100% |
E9AJA6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 89% |
V5AQ10 | Trypanosoma cruzi | 48% | 100% |